This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Daiichi Sankyo Co., Ltd.

Drug Names(s): U31784, U3 1784

Description: U3-1784 is a human monoclonal antibody specifically raised against the Fibroblast Growth Factor Receptor 4 (FGFR4).

Partners: BioInvent International AB

U3-1784 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug